SPIRE SIGN IN Register

Spirethoughts

Spire's six most recent Spirethoughts.

Will cost-effective compost rejuvenate African agriculture
Will compost turn out to be the magic mineral for African agriculture?
Will emerging countries dominate the pool of global megacities in futu...
Thumbnail_Will the tech sector create new employment opportunities for persons with disabilities
Will the tech sector create new employment opportunities for persons w...
Thumbnail_Spirethoughts_Can permanent research bases for human beings be built on the moon
Will 3D printing enable the construction of permanent facilities on th...
Will Africa become the latest global aviation hot-spot
Will Africa become the latest global aviation hot-spot?
Will air taxis become the latest urban transport innovation_
Will air taxis become the latest urban transport innovation?

Indian pharma industry hit by ban on FDC drugs

The Indian Pharmaceutical industry – with a market size of INR1 lakh crore (as of 2016) – faces a loss of approximately INR10,000 crore due to the unforeseen ban of 344 Fixed Dose Combination (FDC) Drugs by the government.

The ban discontinues the sale and manufacture of popular brands like Vicks Action 500 Extra – from Procter & Gamble (P&G) – a Fast-Moving Consumer Goods (FMCG), among others.

Pharma giants Abbott, Pfizer and Macleods Pharma have urged a stay or lifting of the ban. With 1,000 cases under scrutiny, the industry is bound to see more legal battles.

FDC drugs are banned in UK and the US due to health risks they pose such as anti-microbial resistance and even organ failure.

How will India’s Pharma market pick itself up from the FDC drugs ban?


For media enquiries, please contact:

Nidhi Singh
Assistant Manager, Group Corporate Communications
Spire Research and Consulting
Phone: (91) 124 646 5499
E-mail: nidhi.singh@spireresearch.com

Back to Top

Back to Home
BTBTBTBTBTBT